Atorvastatin Calcium Tablets Recalled for Failed Dissolution Specifications
Ascend Laboratories is recalling specific lots of Atorvastatin Calcium Tablets 40 mg due to failed dissolution specifications. Affected lots are distributed nationwide in 90-count, 500-count, and 1000-count packages.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a quality defect in a prescription medication. Failed dissolution specifications present a risk-of-harm scenario in which patients may not receive proper medication dosing. No illnesses or injuries have been reported, consistent with a High (3) severity classification.
Plain-English summary
Ascend Laboratories, LLC is recalling certain lots of Atorvastatin Calcium Tablets USP, 40 mg, due to failed dissolution specifications. The medication is a prescription statin distributed nationwide in the United States.
The recall affects the following lot numbers: 25140933 (expires Feb. 2027), 25140477 (expires Dec. 2026), 24144254 (expires Oct. 2026), 24144163 (expires Sep. 2026), and 24143995 (expires Sep. 2026). The affected product is available in three package sizes: 90-count (NDC 67877-513-90), 500-count (NDC 67877-513-05), and 1000-count (NDC 67877-513-10).
Consumers who have purchased affected lots should contact their pharmacist or healthcare provider with any questions about their medication. Patients should not discontinue use of their medication without consulting their healthcare provider.
The recalled product
- Product
- ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)
- Brand
- ATORVASTATIN CALCIUM
- Manufacturer
- Ascend Laboratories, LLC
- Category
- Drug — Prescription Statin
- Hazard
- failed-dissolution
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot#: 25140933
- Exp. Feb. 2027 Lot#: 25140477
- Exp. Dec. 2026 Lot#: 24144254
- Exp. Oct. 2026 Lot#: 24144163
- Exp. Sep. 2026 Lot#: 24143995
- Exp. Sep. 2026
UPCs (3)
- 0367877512051
- 0367877513102
- 0367877514109
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATORVASTATIN CALCIUM
- ModerateAtorvastatin Calcium Tablets Recalled for Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin Calcium tablets recalled nationwide for failed dissolution specifications
FDA (Drugs) · 2025-10-22
- ModerateAtorvastatin Calcium Tablets Recalled Due to Failed Dissolution Specifications
FDA (Drugs) · 2025-10-22
- HighBiocon Pharma atorvastatin calcium tablets recalled for failed dissolution specifications
FDA (Drugs) · 2025-04-09
- HighPrescription atorvastatin bottles recalled for containing wrong medication
FDA (Drugs) · 2024-10-09
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27